History · 3 years
Overview · Sentiment index · updated daily
About the AstraZeneca Earnings Sentiment
Machine-learning signal measuring AstraZeneca earnings sentiment - tracking oncology pipeline momentum, regulatory approval commentary, and pharma sector growth expectations in emerging markets.
Equity sentiment readings are most actionable at the extremes and around earnings cycles. Awareness surges that are not matched by Sentiment moves often precede sharp directional breaks. Single-stock indicators are best read in conjunction with the broader S&P 500 Sentiment to isolate idiosyncratic versus macro-driven moves.
Key drivers
- Earnings estimates and revision trends
- VIX and options skew
- Sector rotation and fund flow data
- Macro data beats / misses relative to consensus
- Short interest and positioning reports
Reading the Sentiment scale
- 0-20Extreme BearishCoverage dominated by risk-aversion signals; narrative heavily skewed toward bearish conditions.
- 21-40BearishBelow-neutral conditions with cautious market positioning; optimism subdued relative to the 30-day baseline.
- 41-60NeutralBalanced coverage with no clear directional bias. Market is in a wait-and-see posture, awaiting a catalyst.
- 61-80Now · 67BullishPositive momentum building in the narrative; coverage tilting toward bullish catalysts and upside scenarios.
- 81-100Extreme BullishElevated risk of mean-reversion. Watch for sentiment exhaustion signals and divergence from the Awareness score.
How to use this index
- Use the Sentiment score to gauge the prevailing narrative bias for AstraZeneca at a glance.
- The Awareness score flags unusual spikes in coverage - early-warning signals that often precede price moves.
- Extreme readings (0-20 or 81-100) historically mark periods of heightened volatility and potential reversals.
- Compare across related topics to find cross-asset divergences and correlation breakdowns.
- Pro subscribers can view 3 years of history to calibrate thresholds against past market regimes.
This index is frequently referenced alongside astrazeneca earnings sentiment, pharma outlook, ai biotech sentiment, internet earnings discussion, alternative data equities - helping traders and analysts track AstraZeneca sentiment shifts in real time.
Latest news
AstraZeneca in the news
The headlines feeding this index, newest first.
AstraZeneca, Bristol Myers deny merger talks
AstraZeneca and Bristol Myers Squibb are pushing back hard against fresh merger speculation, a sign that even a flat denial can move two of the world’s biggest drugmakers when investors are hunting for the next wave of scale and pipeline consolidation in pharma.
Read moreAstraZeneca tozorakimab cuts COPD flare-ups in trials
AstraZeneca said its experimental COPD drug tozorakimab cut moderate and severe flare-ups by about 30% in late-stage studies, a result that could expand treatment options for millions of patients and strengthen the drugmaker’s respiratory pipeline.
Read moreMeta, Apple, Rheinmetall, AstraZeneca analyst calls
Wall Street’s latest calls on Meta, Apple, Rheinmetall and AstraZeneca point to a market where investors are still rewarding AI exposure and penalizing businesses where earnings momentum looks less certain, even when the underlying products remain strong.
Read moreAstraZeneca pipeline and biotech platform investing
Biotech is moving from isolated lab breakthroughs to platform-driven dealmaking, and that shift is creating a clearer investment case for companies that can turn science into multiple shots on goal.
Read moreAmgen, AstraZeneca cancer trial meets endpoint
Amgen and AstraZeneca have cleared a major late-stage hurdle in oncology, with their cancer drug combination meeting the final phase trial’s primary endpoint on survival — a result that could broaden the commercial case for both companies’ precision-cancer portfolios and sharpen investor focus on who controls the next wave of high-value oncology data.
Read moreAstraZeneca Holds Analyst Support as Shares Pull Back
AstraZeneca is still getting the benefit of the doubt from Oddo BHF at a time when the wider pharmaceutical sector is being reminded how quickly a promising pipeline can turn brittle.
Read moreAstraZeneca wins FDA approval for breast cancer drug
AstraZeneca won U.S. regulatory clearance for an advanced breast cancer treatment, a development that strengthens one of the company’s most important oncology franchises and gives investors another potential contributor to revenue growth as its legacy drugs face patent pressure.
Read moreAstraZeneca Wins US Approval for Etcamah
AstraZeneca has won US approval for Etcamah in a combination treatment for advanced hormone receptor-positive breast cancer, giving the drugmaker a new way to challenge endocrine resistance in one of oncology’s largest markets.
Read moreAstraZeneca, Bristol-Myers Squibb Deny Merger Talks
AstraZeneca and Bristol-Myers Squibb have no merger discussions underway, cutting off speculation that had briefly lifted the pair and redirecting attention to the harder question for investors: whether both drugmakers can keep growing without resorting to a transformational deal.
Read moreAstraZeneca Shares Rise on Oncology Growth
AstraZeneca’s stock has been rewarded for something investors always want to see in big pharma: durable growth from cancer medicines that can keep compounding long after the latest market swing fades.
Read moreEmbed
Put this indicator on your site
Add the live gauge to your page, or share it with your audience.
Methodology
How the index is built
Data sources, scoring and update cadence, in plain terms.
What is the AstraZeneca index?
Machine-learning signal measuring AstraZeneca earnings sentiment - tracking oncology pipeline momentum, regulatory approval commentary, and pharma sector growth expectations in emerging markets.
How is the AstraZeneca index calculated?
The AstraZeneca index is derived from AI-powered NLP analysis of thousands of online news sources, blogs, and financial commentary. Sentiment scores range from 0 (Extreme Bearish) to 100 (Extreme Bullish), where 50 represents neutral conditions. Awareness scores capture the volume and breadth of coverage for this topic across the media landscape.
How often is the AstraZeneca index updated?
The underlying data pipeline runs once per day. However, the gauge and score displayed on this page reflect a processed snapshot that may be 3–24 hours behind real-time, depending on the topic's update cadence and how quickly new data clears the processing pipeline. The exact timestamp of the data shown is visible in the gauge footer - hover the info icon to see it in your local time.
Why does the gauge show data from a few hours ago?
The gauge reflects a processed data snapshot, not a live feed. Depending on the topic, displayed values can be 3–24 hours behind real-time - fast-moving topics (crypto, equities) update more frequently, while slower-cycle topics (macro, real estate, geopolitics) may have a longer lag. The precise data timestamp is always visible in the gauge footer: hover the info icon to see it in your local time.
Why use sentiment analysis?
Sentiment uses natural language processing to analyze and quantify investors' opinions, which is different from traditional indicators like volatility (VIX), volume, or price trends. This gives you an edge over others who rely solely on price-based data.
How to interpret the figures?
The gauges show the latest indicator percentiles for the last two quarters. Values above 50 mean an upward trend, while below 50 means a downward trend. A reading above 70% signals greed, and below 30% signals fear. When price and sentiment trends diverge, it's a strong sign the trend will continue.
What does awareness represent?
Besides sentiment, we also provide a measurement of awareness - an indicator of media activity expressed as a ratio of topic-dedicated data compared to the total. Values over 50 indicate an increasing media trend and growing investors' interest; less than 50 signals decreasing attention.
What is sentiment analysis and why measure it?
Sentiment analysis is a way to determine whether a piece of text is positive, negative, or neutral. It helps understand how people feel about a topic or product, which is very important for investment, revenue management, and gauging public opinion. It adds important data points to the decision process and is valuable input for many statistical and AI models.
What are some of the key data characteristics?
Raw signals are gathered from proprietary sources covering over 50,000 outlets and ingested every 15 minutes. Processed gauge readings are derived from these signals but are displayed with a delay of 3–24 hours depending on the topic - the exact data timestamp is always shown in the gauge footer. The platform includes 5 years of history, supports 72 languages, and processes over 1 million unique entries daily. Adalytica maintains over 99.5% uptime across all products and data services.
Who benefits the most from the sentiment data?
The products are widely used across various industries, including finance, real estate, cryptocurrency, commodities, and government. They provide tailored insights for tasks like tracking voter sentiment, optimizing investment strategies, or monitoring brand perception. We offer products that are tailored for both beginners and advanced data professionals.